UNLABELLED: Basilar artery occlusion is a rare cause of stroke with a high case fatality rate and an often poor clinical outcome among survivors. Our limited knowledge on the outcome in patients with basilar artery occlusion comes from small case series of selected patients. STUDY AIM: The main purpose of the registry is to collect preliminary data that will help direct the design of a future clinical treatment trial. The target number of patients included is 500. DESIGN: BASICS is a prospective, observational, multi-center, international registry of consecutive patients presenting with a symptomatic and radiologically confirmed basilar artery occlusion. STUDY OUTCOMES: From November 2002 until December 2006 data have been collected on 400 patients, from 42 centers in 12 countries. Most patients were treated with IA therapy (55%), followed by antithrombotics (29%) and IV thrombolysis (6%). The overall mortality was 45%.
UNLABELLED: Basilar artery occlusion is a rare cause of stroke with a high case fatality rate and an often poor clinical outcome among survivors. Our limited knowledge on the outcome in patients with basilar artery occlusion comes from small case series of selected patients. STUDY AIM: The main purpose of the registry is to collect preliminary data that will help direct the design of a future clinical treatment trial. The target number of patients included is 500. DESIGN: BASICS is a prospective, observational, multi-center, international registry of consecutive patients presenting with a symptomatic and radiologically confirmed basilar artery occlusion. STUDY OUTCOMES: From November 2002 until December 2006 data have been collected on 400 patients, from 42 centers in 12 countries. Most patients were treated with IA therapy (55%), followed by antithrombotics (29%) and IV thrombolysis (6%). The overall mortality was 45%.
Authors: Philip M Meyers; H Christian Schumacher; E Sander Connolly; Eric J Heyer; William A Gray; Randall T Higashida Journal: Circulation Date: 2011-06-07 Impact factor: 29.690
Authors: Annette Compter; Erik J R J van der Hoeven; H Bart van der Worp; Jan Albert Vos; Christian Weimar; Christina M Rueckert; L Jaap Kappelle; Ale Algra; Wouter J Schonewille Journal: J Neurol Date: 2014-11-25 Impact factor: 4.849
Authors: Joseph D Burns; Rima Sestokas Rindler; Christopher Carr; Helena Lau; Anna M Cervantes-Arslanian; Deborah M Green-LaRoche; Rony Salem; Carlos S Kase Journal: Neurocrit Care Date: 2016-04 Impact factor: 3.210
Authors: Erik Jrj van der Hoeven; Ale Algra; Jan Albert Vos; Heinrich P Mattle; Christian Weimar; Wouter J Schonewille; Jaap Kappelle Journal: Eur Stroke J Date: 2016-10-12
Authors: Mervyn D I Vergouwen; Annette Compter; David Tanne; Stefan T Engelter; Heinrich Audebert; Vincent Thijs; Gabriel de Freitas; Ale Algra; L Jaap Kappelle; Wouter J Schonewille Journal: J Neurol Date: 2012-04-18 Impact factor: 4.849